2025 cell therapy CDMO pricing data and benchmarking report
Over 50 capability profiles of CDMOs specializing in cell therapy
Over 800 hours of data collection for cell therapy manufacturing market intelligence
Scientific analysis of cell therapy development and applications
Essential market insights for CDMOs, innovators and investors
Measure your business against your peers using our robust analysis of the cell therapy contract development and manufacturing market. Our pricing matrix comprises material cost, infrastructure and development process data from CDMOs all over the world so you can make informed decisions to best position your business.
The 2024 Market Insight report provides in-depth research into the current state of applications, development, and manufacturing of cell therapies, including allogeneic and autologous cell therapies. We provide you with essential information from innovators, CDMO owners, PhDs and researchers across advanced therapeutics to fully understand cell therapies' role in the future of healthcare.
Competitive benchmarking data from cell therapy CDMOs all over the world
50+ company profiles of companies specializing in cell therapies
Scientific analysis of the cell therapy development and manufacturing process
Unique benefits and complexities of cell therapies in regards to accessibility, cost and applications
Investment outlook of the cell therapy market — analyzing economic and regulatory conditions
Innovations and breakthroughs that are powering cell therapy development and manufacturing
Over 800 hours of data collection and analysis from
interviews, primary research and progressive study.